TD Cowen Maintains Buy on Twist Bioscience, Raises Price Target to $190
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
TD Cowen analyst Brendan Smith maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $115 to $190.
TD Cowen analyst Brendan Smith maintains Twist Bioscience (NASDAQ:TWST) with a Buy and raises the price target from $115 to $190.